A business in context

MREO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-18 · 0001193125-26-356168 · Items 3.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-343533

  3. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-343519 · Items 2.02,9.01

  4. 8-K · Current report

    Report date 2026-08-11 · 0001193125-26-343482 · Items 1.01,7.01,9.01

  5. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-223071 · Items 5.07,9.01

  6. 8-K/A · Current report

    Report date 2026-05-12 · 0001193125-26-218290 · Items 2.02,9.01

  7. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-218232

  8. 8-K · Current report

    Report date 2026-05-12 · 0001193125-26-218192 · Items 2.01,9.01

  9. DEF 14A · Proxy statement

    Report date 2026-04-08 · 0001193125-26-148832

  10. 8-K · Current report

    Report date 2026-03-26 · 0001193125-26-127253 · Items 5.02

  11. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-115226

  12. 8-K · Current report

    Report date 2026-03-19 · 0001193125-26-115211 · Items 2.02,9.01

  13. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082838

  14. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082835

  15. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082831

  16. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082830

  17. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082826

  18. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082820

  19. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082818

  20. 4 · Ownership change

    Report date 2026-02-26 · 0001193125-26-082815

  21. 8-K · Current report

    Report date 2026-02-17 · 0001193125-26-054787 · Items 3.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009829 · Items 7.01,8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-29 · 0001193125-25-332520 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-274319 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-274272

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-178489

  27. 8-K · Current report

    Report date 2025-08-12 · 0000950170-25-106924 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-07-09 · 0000950170-25-094921 · Items 8.01

  29. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-071485 · Items 5.07,9.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069816

  31. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-069811 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-05-13 · 0000950170-25-051800

  33. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-044787

  34. 8-K · Current report

    Report date 2025-03-26 · 0000950170-25-044783 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-01-12 · 0000950170-25-004523 · Items 7.01,9.01

  36. SC 13G/A · Ownership disclosure

    0001274173-24-000113

  37. SC 13G/A · Ownership disclosure

    0001213900-24-098321

  38. SC 13G/A · Ownership disclosure

    0000919574-24-006740

  39. SC 13G/A · Ownership disclosure

    0001172661-24-004586

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-124637

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001719714Mereo BioPharma Group plc

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0
    2023-12-31$10.00M$10.96M
    2022-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗